P09.01 Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group

The objective of this phase I/II study was to examine the efficacy and toxicity profile of temozolomide (TMZ) plus nimustine (ACNU). Patients who had received a standard radiotherapy with one or two previous chemo-regimens were enrolled. In phase I, the maximum-tolerated dose (MTD) by TMZ (150 mg/m2...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Aoki, T., Arakawa, Ueba, Oda, Nishida, Akiyama, Tsukahara, Iwasaki, Mikuni, Miyamoto
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
POSTER PRESENTATIONS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.259
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki